ReviewClinical and experimental dermatology2016

Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.

V R Belum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.